Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome - Keyvan Razazi; Enora Berti; Jerome Cecchini; Guillaume Carteaux; Anoosha Habibi; Pablo Bartolucci; Romain Arrestier; Ségolène Gendreau; Nicolas de Prost; Anne Hulin; Armand Mekontso Dessap (PLoS ONE, 2025)